BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23856826)

  • 21. Incidental Finding of Intrathyroid Metastases of Prostatic Cancer on 18F-Choline PET/CT.
    Vija Racaru L; Gabiache E; Fontaine S; DʼAure D; Mourey L; Courbon F; Zerdoud S
    Clin Nucl Med; 2019 Feb; 44(2):e101-e103. PubMed ID: 30516690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Squamous cell carcinoma of the tonsil incidentally detected by 18F-choline PET/CT.
    Treglia G; Ceriani L; Barizzi J; Bertagna F; Giovanella L
    Clin Nucl Med; 2015 Jan; 40(1):93-5. PubMed ID: 24662666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer.
    Goineau A; Colombié M; Rousseau C; Sadot-Lebouvier S; Supiot S
    Clin Nucl Med; 2015 Aug; 40(8):670-1. PubMed ID: 26018683
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Ferda J; Ferdová E; Baxa J; Fínek J; Topolčan O
    Anticancer Res; 2018 Jul; 38(7):4139-4143. PubMed ID: 29970541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
    Brindle R; Mullan D; Yap BK; Gandhi A
    Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading.
    Langsteger W; Balogova S; Huchet V; Beheshti M; Paycha F; Egrot C; Janetschek G; Loidl W; Nataf V; Kerrou K; Pascal O; Cussenot O; Talbot JN
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):448-57. PubMed ID: 21738117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [18F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.
    Poulsen MH; Bouchelouche K; Gerke O; Petersen H; Svolgaard B; Marcussen N; Svolgaard N; Ogren M; Vach W; Høilund-Carlsen PF; Geertsen U; Walter S
    BJU Int; 2010 Sep; 106(5):639-43; discussion 644. PubMed ID: 20089104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pitfalls with 18F-choline PET/CT in patients with prostate cancer].
    García Vicente AM; Núñez García A; Soriano Castrejón AM; Jiménez Londoño GA; Cordero García JM; Palomar Muñoz A
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):37-9. PubMed ID: 23177342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supraclavicular metastasis in prostate cancer detected with 18F-fluorocholine PET/CT.
    Núñez Miller R; Viera JC; Jover Díaz R; Rojo Sebastián A; Pozo MA; Alfonso Alfonso JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(1):44-6. PubMed ID: 21719158
    [No Abstract]   [Full Text] [Related]  

  • 30. 18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
    Bauman G; Belhocine T; Kovacs M; Ward A; Beheshti M; Rachinsky I
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):45-55. PubMed ID: 21844889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorodeoxyglucose positron emission tomography in primary thyroid lymphoma with coexisting lymphocytic thyroiditis.
    Arabi M; Dvorak R; Smith LB; Kujawski L; Gross MD
    Thyroid; 2011 Oct; 21(10):1153-6. PubMed ID: 21875367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization.
    Kim YI; Cheon GJ; Paeng JC; Cho JY; Kwak C; Kang KW; Chung JK; Kim EE; Lee DS
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1247-56. PubMed ID: 25759164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidental Meningioma Detected on 18F-Fluoride With PET/CT During Initial Staging for Prostate Cancer.
    Teo TY; Menda Y; McNeely P; Kahn D; Graham M
    Clin Nucl Med; 2015 Jul; 40(7):596-7. PubMed ID: 25899597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of extraprostatic disease in the staging of prostate cancer by F-18 choline PET/CT: can PSA and PSA density help in patient selection?
    Calabria F; Chiaravalloti A; Tavolozza M; Ragano-Caracciolo C; Schillaci O
    Nucl Med Commun; 2013 Aug; 34(8):733-40. PubMed ID: 23680652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.
    Häcker A; Jeschke S; Leeb K; Prammer K; Ziegerhofer J; Sega W; Langsteger W; Janetschek G
    J Urol; 2006 Nov; 176(5):2014-8; discussion 2018-9. PubMed ID: 17070241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How we read FCH-PET/CT for prostate cancer.
    Beauregard JM; Beaulieu A
    Cancer Imaging; 2016 Dec; 16(1):41. PubMed ID: 27923396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidental detection of colorectal cancer via 1(8)F-choline PET/CT in a patient with recurrent prostate cancer: usefulness of early images.
    Bagni O; Filippi L; Schillaci O
    Clin Nucl Med; 2015 Jun; 40(6):e328-30. PubMed ID: 25674873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
    Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR
    J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates.
    Krause BJ; Souvatzoglou M; Treiber U
    Urol Oncol; 2013 May; 31(4):427-35. PubMed ID: 21388835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of colon cancer incidentally detected by 18F-choline PET/CT.
    Calabria FF; Crusco S; Cicciò C; Schillaci O
    Clin Nucl Med; 2013 Dec; 38(12):982-3. PubMed ID: 24097002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.